Enhanced expression of ten‐eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P‐glycoprotein expression

Enhanced expression of ten‐eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P‐glycoprotein expression

Abstract Increasing evidence revealed that ten‐eleven translocation 1 (TET1) plays an important role in tumorigenesis and chemoresistance, but its functions in gemcitabine resistance in cholangiocarcinoma (CCA) remain unknown. This study aims to investigate the effect of TET1 on gemcitabine resistan...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chuanxu Wang, Hua Ye, Lei Zhang, Yayu Cheng, Shifeng Xu, Ping Zhang, Zijie Zhang, Jimin Bai, Fangkang Meng, Lin Zhong, Guangjun Shi, Hao Li
Format:	Article
Language:	English
Published:	Wiley 2019-03-01
Series:	Cancer Medicine
Subjects:	chemotherapy resistance cholangiocarcinoma gemcitabine P‐gp TET1
Online Access:	https://doi.org/10.1002/cam4.1983
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hepatic arterial infusion chemotherapy with Folfox 4 regimen versus cisplatin and gemcitabine for locally advanced intrahepatic cholangiocarcinoma
by: Lin Liu, et al.
Published: (2025-07-01)

Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience
by: Fatih Kuş, et al.
Published: (2025-08-01)

PPM1G Inhibits Epithelial–Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter
by: Wenzheng Liu, et al.
Published: (2024-12-01)

Improved Antitumor Efficiency of N4-Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy
by: Wang D, et al.
Published: (2024-12-01)

CircRNAs modulate response of cancer cells to gemcitabine
by: Zahra Tajik, et al.
Published: (2025-12-01)

Lactate modulates the function of myeloid-derived suppressor cells via Ten-Eleven-Translocation-2-mediated demethylation of glucocorticoid-inducible kinase 1 in lung cancer model
by: Ying Chu, et al.
Published: (2025-08-01)

Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case
by: Masashi Tsunematsu, et al.
Published: (2019-06-01)

ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis
by: Xiaohong Liu, et al.
Published: (2025-08-01)

Promoter demethylation of cerebellin 2 by ten-eleven translocation 3 contributes to peripheral sensitization in trigeminal neuropathic pain of mice
by: Xin-Ying Guan, et al.
Published: (2025-07-01)

Gemcitabine: immunomodulatory or immunosuppressive role in the tumor microenvironment
by: Mahnaz Nemati, et al.
Published: (2025-04-01)

Gemcitabine resistance by CITED4 upregulation via the regulation of BIRC2 expression in pancreatic cancer
by: Eun-Jeong Jeong, et al.
Published: (2025-05-01)

The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre‐clinical study
by: Kaan Low, et al.
Published: (2024-09-01)

PLA2G16 expression predicts prognosis and gemcitabine sensitivity in patients with pancreatic cancer
by: Xiaoyu Sun, et al.
Published: (2025-05-01)

Lycorine hydrochloride inhibits cholangiocarcinoma through cholesterol biosynthesis and PTPN11 nuclear translocation
by: Fengyun Zhao, et al.
Published: (2025-07-01)

Addition of gemcitabine to standard therapy in locally advanced cervical cancer: A randomized comparative study
by: Sanjoy Roy, et al.
Published: (2011-01-01)

Gemcitabine combined with baicalein exerts antiviral activity against PEDV by inhibiting the entry and replication phases
by: Yingge Zheng, et al.
Published: (2025-02-01)

Physiogenomics in etiopathogenesis of cholangiocarcinoma
by: Beuy Joob, et al.
Published: (2017-01-01)

Surgical treatment of peripheral hepatic cholangiocarcinoma with a visceral vein invasion
by: О. Yu. Usenko, et al.
Published: (2020-09-01)

Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01)

Synthesis and properties of magnetically sensitive nanocomposites based on magnetite and gemcitabine
by: A. L. Petranovska, et al.
Published: (2018-11-01)

ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel
by: Susy Shim, et al.
Published: (2025-06-01)

NCOA6 knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine
by: Jia Yuming, et al.
Published: (2025-03-01)

First case report of neoadjuvant gemcitabine and S-1 for locally advanced unresectable duodenal adenocarcinoma
by: Jiro Kimura, et al.
Published: (2022-05-01)

FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma
by: Tung-Wei Hsu, et al.
Published: (2025-02-01)

Multiple cholangiocarcinomas in the intrahepatic and extrahepatic biliary tree due to dichloromethane exposure: a case report
by: Daisuke Ogawa, et al.
Published: (2020-04-01)

Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis
by: Jiaqiang Ren, et al.
Published: (2025-04-01)

Acute pancreatitis caused by pemetrexed, carboplatin, and gemcitabine in a patient with lung cancer: A rare case report
by: Vishal Kulkarni, et al.
Published: (2019-01-01)

Expression and molecular insights of lima1 in cholangiocarcinoma
by: Halmurat Obulkasim, et al.
Published: (2024-12-01)

One-pot construction of gemcitabine loaded zeolitic imidazole framework for the treatment of lung cancer and its apoptosis induction
by: Zhan Li, et al.
Published: (2023-12-01)

The efficacy and safety of gemcitabine and docetaxel in pseudomyogenic hemangioendothelioma: a multi-center experience
by: Qiyan Cai, et al.
Published: (2025-07-01)

Analysis of risk factors of cholangiocarcinoma, role of diabetes mellitus and hepatitis B virus infection in the intrahepatic and extrahepatic cholangiocarcinoma: a retrospective case-based study in China
by: Hasan Md Rasadul, et al.
Published: (2025-07-01)

Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024
by: Dandan Gu, et al.
Published: (2025-04-01)

Differential expression of ten-eleven translocation genes in endometrial cancers
by: Piotr Ciesielski, et al.
Published: (2017-03-01)

An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
by: REN Jiaqiang, WU Shuai, SU Tong, LI Jie, HAN Liang, WU Zheng
Published: (2024-12-01)

Modification of gemcitabine with oxaliplatin in China for unresectable gallbladder cancer: a cost-effectiveness analysis
by: Zhaoyan Chen, et al.
Published: (2024-12-01)

An Imine-Based Two-Dimensional Covalent Organic Framework for Gemcitabine Delivery
by: Kajal Kaliya, et al.
Published: (2025-01-01)

Muscle invasive bladder cancer treated with gemcitabine plus cisplatin as neoadjuvant chemotherapy during the second trimester of pregnancy
by: Takeshi Sasaki, et al.
Published: (2025-03-01)

MLN0905 effectively kills gemcitabine-resistant pancreatic cancer cells by targeting PLK1
by: Min Lin, et al.
Published: (2025-07-01)

Aberrant high expression of the TET1 gene in Hirschsprung's disease
by: Shaobo Yang, et al.
Published: (2022-07-01)

Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation
by: Yaheng Wu, et al.
Published: (2025-09-01)